Common Contracts
2 similar Joint Patent Agreement contracts by CardioVascular BioTherapeutics, Inc.
EX-10.1 2 dex101.htm JOINT PATENT AGREEMENT JOINT PATENT AGREEMENT February 28, 2007Joint Patent Agreement • May 5th, 2020 • California
This Joint Patent Agreement (the “Agreement”) entered into as of the 28th day of February 2007 (the “Effective Date”) between CardioVascular BioTherapeutics, Inc. (“CARDIO”), whose principal place of business is at 1635 Village Center Circle, Suite 250, Las Vegas, NV 89134, and Phage Biotechnology Corporation (“PHAGE”), whose principal place of business is at 1635 Village Center Circle, Suite 260, Las Vegas, NV 89134.
JOINT PATENT AGREEMENT February 28, 2007Joint Patent Agreement • March 29th, 2007 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations • California
This Joint Patent Agreement (the “Agreement”) entered into as of the 28th day of February 2007 (the “Effective Date”) between CardioVascular BioTherapeutics, Inc. (“CARDIO”), whose principal place of business is at 1635 Village Center Circle, Suite 250, Las Vegas, NV 89134, and Phage Biotechnology Corporation (“PHAGE”), whose principal place of business is at 1635 Village Center Circle, Suite 260, Las Vegas, NV 89134.
